Cell Biology International · 2014 · 43 citations · 27 references
Life SciencesEndocrinologyOncologyCell SignalingMolecular OncologySignal TransductionG Protein-coupled Receptor SignalingGonadal HormonesHormone SignalingOvarian CancerSteroid Hormone SignalingCell Cycle InhibitionCell Proliferation IndicesCell Proliferation StimulationCyclin RegulationEstrogen Receptor SignalingEstrogen ReceptorsNon-genomic Signaling
G protein-coupled estrogen receptor (GPER) is recently identified as a membrane-associated estrogen receptor that mediates non-genomic effects of estrogen. Our previous immunohistochemistry study found an association between GPER and the proliferation of epithelial ovarian cancer. However, the contributions and mechanisms of GPER in the proliferation of ovarian cancers are not clear. We have examined the role of GPER in estrogen receptor α (ERα)-negative/GPER positive OVCAR5 ovarian cancer cell line. MTT assay was used to detect cell proliferation. BrdU incorporation assay was used to measure the cells in S-phase. Protein expression of marker genes of proliferation, cell cycle and apoptosis were examined by Western blot. The results showed that 17β-estradiol and selective GPER agonist G-1 stimulated the proliferation of OVCAR5 cells and increased the cells in S-phase. Both ligands upregulated the protein levels of c-fos and cyclin D1. Small interfering RNA targeting GPER or G protein inhibitor pertussin toxin (PTX) inhibited basal cell proliferation and attenuated 17β-estradiol- or G-1-induced cell proliferation. GPER mediated cell growth was also associated with the apoptosis of OVCAR5 cells. These findings suggest that GPER has an important function in the proliferation of ovarian cancer cells lacking ERα. GPER might be a promising therapeutic target in ovarian cancer.
27
Ahmedin Jemal, Rebecca L. Siegel, Elizabeth M. Ward et al. · CA A Cancer Journal for Clinicians · 2006 · 5.3K citations · Full text
A Transmembrane Intracellular Estrogen Receptor Mediates Rapid Cell Signaling
Chetana M. Revankar, Daniel F. Cimino, Larry A. Sklar et al. · Science · 2005 · 2.3K citations
Edward J. Filardo, Jeffrey A. Quinn, A. Raymond Frackelton et al. · Molecular Endocrinology · 2002 · 854 citations · Full text
Virtual and biomolecular screening converge on a selective agonist for GPR30
Cristian Bologa, Chetana M. Revankar, Susan Young et al. · Nature Chemical Biology · 2006 · 814 citations · Full text
Menopausal Hormone Replacement Therapy and Risk of Ovarian Cancer
James V. Lacey · JAMA · 2002 · 617 citations
Medicine, Gynecology, Oncology +12